Table 2 |
|||||
|
Plasma tocopherols (T) concentrations after supplementation with the α-tocopherol or tocotrienol-rich fraction (TRF) treatments (Mean values ± SEM, n = 10). |
|||||
|
α-T |
TRF |
||||
|
|
|
||||
|
α-T |
γ-T |
α-T |
γ-T |
||
|
μM |
|||||
|
|
|||||
|
0 h* |
23.38 ± 1.03 |
0.36 ± 0.12 |
22.95 ± 1.26 |
0.35 ± 0.15 |
|
|
2 h |
26.31 ± 1.81 |
0.63 ± 0.15 |
22.98 ± 1.20 |
0.57 ± 0.18 |
|
|
Change† |
2.90 ± 1.63 |
0.29 ± 0.14 |
0.05 ± 0.65 |
0.22 ± 0.17 |
|
|
4 h |
32.65 ± 2.49‡ |
1.42 ± 0.12‡ |
26.45 ± 1.89‡ |
1.70 ± 0.28‡ |
|
|
Change |
9.26 ± 1.00 |
1.06 ± 0.17 |
3.51 ± 1.23 |
1.34 ± 0.34 |
|
|
5 h |
36.38 ± 3.17‡ |
1.64 ± 0.15‡ |
28.15 ± 2.61‡ |
1.96 ± 0.40‡ |
|
|
Change |
12.98 ± 2.79 |
1.27 ± 0.22 |
5.20 ± 1.93 |
1.61 ± 0.46 |
|
|
6 h |
37.4 ± 3.51‡ |
1.57 ± 0.17‡ |
30.13 ± 2.91‡ |
2.15 ± 0.41‡ |
|
|
Change |
14.00 ± 3.25 |
1.22 ± 0.19 |
7.17 ± 2.18 |
1.80 ± 0.48 |
|
|
8 h |
37.8 ± 3.59‡ |
1.48 ± 0.27‡ |
29.79 ± 2.30‡ |
1.76 ± 0.22‡ |
|
|
Change |
14.39 ± 3.32 |
1.13 ± 0.29 |
6.85 ± 1.39 |
1.42 ± 0.29 |
|
|
24 h |
32.92 ± 3.58 |
0.35 ± 0.16 |
26.79 ± 1.81 |
0.20 ± 0.11 |
|
|
Change |
9.52 ± 3.41 |
-0.02 ± 0.17 |
3.83 ± 1.07 |
-0.14 ± 0.19 |
|
|
AUC 24 h |
353.52 ± 30.40§ |
9.92 ± 1.68 |
286.16 ± 19.85§ |
11.10 ± 1.47 |
|
|
|
|||||
|
T, tocopherols; TRF, tocotrienol-rich fraction; AUC, area under the curve (arbitrary unit); α-T, alpha-tocopherol; γ-T, γ-tocopherol. * No significant differences in plasma α-T and γ-T concentrations at baseline (0 h) were found between the treatments. † Changes were calculated as the difference between values at each postprandial interval and baseline (0 h). ‡ Significant increment from baseline (0 h) value, P < 0.05 (Wilcoxon's signed-ranks test). § Significant difference of AUC for α-T between the treatments, P < 0.05 (Wilcoxon's signed-ranks test). |
|||||
|
Fairus et al. Nutrition Journal 2012 11:5 doi:10.1186/1475-2891-11-5 |
|||||